Aardvark Therapeutics, Inc. Common Stock
USD5.52
+0.34 (+6.56%)
CEO
Tien-Li Lee
IPO Date
2025-02-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.19
Prev. Close
$5.18
Day Low
$5.08
Day High
$5.53
52W Low
$3.35
52W High
$17.94
Market Cap
$0.12B
Volume
0.11M
| 70,549 |
| $13.48 |
| 11 Feb 2026 | Lee Tien-Li | director, 10 percent owner, officer: Chief Executive Officer | A-Award | Disposed | 203,851 | $13.48 |
| 12 Dec 2025 | Sun Nelson | Chief Financial Officer | P-Purchase | Acquired | 3,000 | $14.40 |
| 12 Dec 2025 | Lee Tien-Li | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 7,000 | $14.48 |
| 16 Oct 2025 | Lee Tien-Li | director, 10 percent owner, officer: Chief Executive Officer | M-Exempt | Acquired | 1,229 | $4.24 |
| 16 Oct 2025 | Lee Tien-Li | director, 10 percent owner, officer: Chief Executive Officer | M-Exempt | Disposed | 1,229 | $4.24 |
| 16 Oct 2025 | Jones Bryan | Chief Operating Officer | M-Exempt | Acquired | 1,250 | $4.24 |
| 16 Oct 2025 | Jones Bryan | Chief Operating Officer | M-Exempt | Disposed | 1,250 | $4.24 |
| 16 Sept 2025 | Lee Tien-Li | director, 10 percent owner, officer: Chief Executive Officer | P-Purchase | Acquired | 6,500 | $9.51 |